Financial Snapshot

Revenue
$41.11M
TTM
Gross Margin
40.89%
TTM
Net Earnings
-$108.2M
TTM
Current Assets
Q3 2023
Current Liabilities
Q3 2023
Current Ratio
322.22%
Q3 2023
Total Assets
Q3 2023
Total Liabilities
Q3 2023
Book Value
$45.13M
Q3 2023
Cash
Q3 2023
P/E
-0.4933
Feb 23, 2024 EST
Free Cash Flow
-$75.89M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2022 2021 2020 2019 2018 2017

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2022 2021 2020 2019 2018 2017

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2022 2021 2020 2019 2018 2017

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2022 2021 2020 2019 2018 2017

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2022 2021 2020 2019 2018 2017

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2022 2021 2020 2019 2018 2017

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2022 2021 2020 2019 2018 2017

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $53.359 Million

About Eargo, Inc.

Eargo, Inc. is engaged in the development of hearing aids and headsets solutions. The company is headquartered in San Jose, California and currently employs 243 full-time employees. The company went IPO on 2020-10-16. The firm is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. The company is marketing various versions of hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, Eargo 6 and Eargo 7. The firm markets and sells its hearing aids primarily in a direct-to-consumer format, engaging consumers through a mix of digital and traditional marketing as well as select commercial partnership, and omni-channel (including retail). Its devices are self-fitting hearing aids and are adjusted by the user to meet the user’s hearing needs, without pre-programming or a hearing test from a hearing care professional.

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies Peers: ABBOTT LABORATORIES Modular Medical Inc Biomerica Inc Cytosorbents Corp Daxor Corp Kewaunee Scientific Corp Lucira Health, Inc. Pro-Dex Inc